QM/MM study of HCV NS3/NS4A protease with its main substrates: from the structure to the kinetics

被引：0
|
作者：
Martinez, J. A. [1 ]
Martinez, R. [1 ]
Puyuelo, M. P. [1 ]
Masgrau, L. [2 ]
Gonzalez, M. [3 ,4 ]
机构：
[1] Univ La Rioja, Dept Quim, Logrono, Spain
[2] Inst Biotecnol & Biomed, Barcelona, Spain
[3] Univ Barcelona, Dept Quim Fis, E-08007 Barcelona, Spain
[4] Univ Barcelona, IQTC, E-08007 Barcelona, Spain
来源：
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS | 2013年 / 42卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S196 / S196
页数：1
相关论文
共 50 条
  • [41] Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: Elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping
    Landro, JA
    Raybuck, SA
    Luong, YPC
    OMalley, ET
    Harbeson, SL
    Morgenstern, KA
    Rao, G
    Livingston, DJ
    BIOCHEMISTRY, 1997, 36 (31) : 9340 - 9348
  • [42] Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus:: A 2.2 Å resolution structure in a hexagonal crystal form
    Yan, YW
    Li, Y
    Munshi, S
    Sardana, V
    Cole, JL
    Sardana, M
    Steinkuehler, C
    Tomei, L
    De Francesco, R
    Kuo, LC
    Chen, ZG
    PROTEIN SCIENCE, 1998, 7 (04) : 837 - 847
  • [43] Structural Analysis of Asunaprevir Resistance in HCV NS3/4A Protease
    Soumana, Djade I.
    Ali, Akbar
    Schiffer, Celia A.
    ACS CHEMICAL BIOLOGY, 2014, 9 (11) : 2485 - 2490
  • [44] Interaction of HCV NS3 proteinase domain and NS4A: (1) effect of N-terminal biotinylation on NS4A cofactor peptide and (2) genotypic variations on cofactor activities.
    Butkiewicz, NJ
    Wright-Minogue, J
    Zhang, R
    Yao, N
    Baroudy, BM
    Dasmahapatra, B
    Lau, JYN
    Hong, Z
    HEPATOLOGY, 1998, 28 (04) : 321A - 321A
  • [45] New and Efficient Synthesis of HCV NS3/4 A Protease Inhibitor Telaprevir
    Porala, Subbanarasimhulu
    Yerrabelly, Jayaprakash Rao
    Kasireddy, Venkateshwar Reddy
    Yerrabelly, Hemasri
    Ghojala, Venkat Reddy
    Rebelli, Pradeep
    CHEMISTRYSELECT, 2019, 4 (33): : 9523 - 9528
  • [46] Treatment of HCV infection with the novel NS3/4A protease inhibitors
    De Luca, Andrea
    Bianco, Claudia
    Rossetti, Barbara
    CURRENT OPINION IN PHARMACOLOGY, 2014, 18 : 9 - 17
  • [47] Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein
    Neddermann, P
    Clementi, A
    De Francesco, R
    JOURNAL OF VIROLOGY, 1999, 73 (12) : 9984 - 9991
  • [48] HCV NS3 Blocking Effect on IFN Induced ISGs Like Viperin and IL28 With and Without NS4A
    Khanlari, Zahra
    Sabahi, Farzaneh
    Hosseini, Seyed Younes
    Ghaderi, Mostafa
    HEPATITIS MONTHLY, 2014, 14 (06)
  • [49] Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus
    Ishido, S
    Fujita, T
    Hotta, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 244 (01) : 35 - 40
  • [50] The therapeutic potential of NS3 protease inhibitors in HCV infection
    Goudreau, N
    Llinàs-Brunet, M
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (09) : 1129 - 1144
12345